Avience Biomedicals Limited Share Price & Stock Analysis

Avience Biomedicals Limited manufactures and sells Vitro-Diagnostic products and medical devices in India. The company's products include reagents and consumables, such as biochemistry reagents, hematology reagents, immunoassay reagents, electrolyte reagents, and cuvettes, pipette tips, test tubes, microplates, and filters; diagnostic instruments and equipment includes automated biochemistry analysers, hematology analysers, immunoassay analysers, molecular diagnostic instruments, microbiology instruments and electrolyte analyser; rapid test kits; molecular test; covid detection kits; petri dishes; other lab equipment; cleaning solutions; oxygen concentrators; culture media; and plastic ware products. In addition, it offers substances used in laboratories to support the growth and multiplication of microorganisms, such as bacteria, fungi, and viruses, and distributes branded equipment. The company also offers post-sales support that includes annual and comprehensive maintenance contract

Key Metrics

Current Price₹277.75
Market Cap₹157 Cr
SectorHealth Care > Health Care Equipment and Services > Health Care Equipment and Supplies
Sub-IndustryHealth Care Equipment > Health Care; Health Care Equipment and Services; Health Care Equipment and Supplies; Health Care Equipment; Medical Testing, Analyzing, and Diagnostic Equipment
P/E Ratio14.5
Beta (1Y)-3.18

Business Segments

1. Diagnostic Kits / Equipment-100%

Frequently Asked Questions

What is the current share price of Avience Biomedicals Limited?

Avience Biomedicals Limited is trading at ₹277.75, with a market capitalisation of ₹157 Cr.

Which sector does Avience Biomedicals Limited belong to?

Avience Biomedicals Limited operates in the Health Care > Health Care Equipment and Services > Health Care Equipment and Supplies space (Health Care Equipment > Health Care; Health Care Equipment and Services; Health Care Equipment and Supplies; Health Care Equipment; Medical Testing, Analyzing, and Diagnostic Equipment).

What are the key financial ratios of Avience Biomedicals Limited?

Avience Biomedicals Limited has a P/E of 14.5.